Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...

ASX could hit record high despite mixed bag on Wall Street. US stocks expected to outperform bonds as Fed cuts rates.

WASHINGTON - Experts expressed enthusiasm after US health regulators approved the first new form of treatment for ...

Significant regulatory news last week included the US Food and Drug Administration (FDA) granting approval for Zevra ...